Skip to main content
SpringerLink
Log in

Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The influence of clonidine on α-adrenoreceptors in the central nervous system of rats and mice has been investigated. Both functional events due to postsynaptic receptor stimulation (flexor reflex activity, motor activity) and biochemical changes have been considered.

  1. 1.

    Clonidine was less potent in stimulating the hindlimb flexor reflex activity of spinal rats than in inhibiting the α-methyltyrosine-induced disappearance of noradrenaline in the spinal cord and in the whole brain of rats.

  2. 2.

    The increase in flexor reflex activity due to clonidine (0.4 mg/kg) was virtually completely inhibited by phenoxybenzamine (20 mg/kg) and haloperidol (10 mg/kg), was partially inhibited by yohimbine (10 mg/kg) and piperoxan (60 mg/kg) and was not significantly inhibited by yohimbine (3 mg/kg) and tolazoline (50 mg/kg).

  3. 3.

    The potentiation by clonidine of the apomorphine-induced locomotor stimulation of reserpinetreated mice was almost completely inhibited by phenoxybenzamine (20 mg/kg) but was not significantly affected by yohimbine (10 or 3 mg/kg) and only slightly inhibited by tolazoline (50 mg/kg).

  4. 4.

    Clonidine (0.1 mg/kg) caused a considerable inhibition of the α-methyltyrosine-induced disappearance of noradrenaline in the spinal cord and brain of rats and in the brain of mice. This effect of clonidine was completely antagonized by yohimbine (10 mg/kg). It was markedly antagonized by yohimbine (3 mg/kg), piperoxan (60 mg/kg) or tolazoline (50 mg/kg) but not by phenoxybenzamine (20 mg/kg) or haloperidol (10 mg/kg).

  5. 5.

    Clonidine (0.1 mg/kg) caused an inhibition of the accumulation of Dopa after decarboxylase inhibition in the noradrenaline-rich regions of the rat central nervous system. This effect was counteracted by yohimbine (10 mg/kg), piperoxan (60 mg/kg) or tolazoline (50 mg/kg) but not by phenoxybenzamine (20 mg/kg).

  6. 6.

    The postsynaptic functional effects and the biochemical effects of clonidine may be due to stimulation of different α-adrenoreceptors since the two effects were inhibited differently by various α-adrenoreceptor blocking agents and since the two effects were produced by different doses of clonidine. The α-adrenoreceptors mediating the biochemical changes might be located on the noradrenergic neurones.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Andén, N.-E., Strömbom, U.: Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity. Psychopharmacologia (Berl.) 38, 91–103 (1974)

    Google Scholar 

  • Andén, N.-E., Strömbom, U., Svensson, T. H.: Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity. Psychopharmacologia (Berl.) 29, 289–298 (1973)

    Google Scholar 

  • Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, T.: Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide. Brit. J. Pharmacol. 34, 1–7 (1968)

    Google Scholar 

  • Andén, N.-E., Fuxe, K., Hamberger, B., Hökfelt, T.: A quantitative study of the nigro-neostriatal dopamine neuron system in the rat. Acta physiol. scand. 67, 306–312 (1966b)

    Google Scholar 

  • Andén, N.-E., Corrodi, H., Dahlström, A., Fuxe, K., Hökfelt, T.: Effects of tyrosine hydroxylase inhibition on the amine levels of central monoamine neurons. Life Sci. 5, 605–611 (1966a)

    Google Scholar 

  • Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, B., Hökfelt, T., Rydin, C., Svensson, T.: Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci. 9, (1), 513–523 (1970)

    Google Scholar 

  • Atack, C. V.: The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay. Brit. J. Pharmacol. 48, 699–714 (1973)

    Google Scholar 

  • Atack, C. V., Magnusson, T.: Individual elution of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from a single, strong cation exchange column, by means of mineral acid-organic solvent mixtures. J. Pharm. Pharmacol. 22, 625–627 (1970)

    Google Scholar 

  • Bacq, Z. M.: Recherches sur la physiologie et la pharmacologie du système nerveux autonome. XXI. Nouvelles recherches sur les actions pharmacodynamiques des dérivés de l'aminométhylbenzodioxane (933 F. notamment), des amines à fonction étheroxyde phénolique et de la yohimbine. Arch. int. Pharmacodyn. 52, 471–492 (1936)

    Google Scholar 

  • Bacq, Z. M., Fredericq, H.: Recherches sur la physiologie et la pharmacologie du système nerveux autonome. XIV. Modifications apportées par deux dérivés de l'aminométhylbenzodioxane (883 F. et 933 F.) aux effets de l'adrénaline et de l'excitation sympathique sur la membrnae nictitante du chat. Arch. int. Physiol. Biochim. 40, 454–466 (1935)

    Google Scholar 

  • Bertler, Å, Carlsson, A., Rosengren, E.: A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta physiol. scand. 44, 273–292 (1958)

    Google Scholar 

  • Bock, K. D., Merguet, P., Murata, T., Heimsoth, V.: Klinischexperimentelle Untersuchungen über die Wirkungen von Dichlorphenylaminoimidazolin. In: Hochdrucktherapie, L. Heilmeyer, H.-J. Holtmeier, and E. F. Pfeiffer, eds., pp. 28–38. Stuttgart: G. Thieme 1968

    Google Scholar 

  • Bovet, D., Bovet-Nitti, F.: Structure et activité pharmacodynamique des médicaments du système nerveux végétatif. Basel: S. Karger 1948

    Google Scholar 

  • Carlsson, A., Davis, J. N., Kehr, W., Lindqvist, M., Atack, C. V.: Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 153–168 (1972)

    Google Scholar 

  • Chess, D., Yonkman, F. F.: Adrenolytic and sympatholytic actions of Priscol (benzyl-imidazoline). Proc. Soc. exp. Biol. (N. Y.) 61, 127–130 (1946)

    Google Scholar 

  • Corrodi, H., Hanson, L. C. F.: Central effects of an inhibitor of tyrosine hydroxylation. Psychopharmacologia (Berl.) 10, 116–125 (1966)

    Google Scholar 

  • Dubocovich, M. L., Langer, S. Z.: Negative feed-back regulation of noradrenaline release by nerve stimulation in the perfused cat's spleen: differences in potency of phenoxybenzamine in blocking the pre- and post-synaptic adrenergic receptors. J. Physiol. (Lond.) 237, 505–519 (1974)

    Google Scholar 

  • Enero, M. A., Langer, S. Z., Rothlin, R. P., Stefano, F. J. E.: Role of the α-adrenoceptor in regulating noradrenaline overflow by nerve stimulation. Brit. J. Pharmacol. 44, 672–688 (1972)

    Google Scholar 

  • Engström, G., Svensson, T. H., Waldeck, B.: Thyroxine and brain catecholamines: increased transmitter synthesis and increased receptor sensitivity. Brain Res. 77, 471–483 (1974)

    Google Scholar 

  • Farnebo, L.-O., Hamberger, B.: Drug-induced changes in the release of [3H]-noradrenaline from field stimulated rat iris. Brit. J. Pharmacol. 43, 97–106 (1971a)

    Google Scholar 

  • Farnebo, L.-O., Hamberger, B.: Drug-induced changes in the release of 3H-monoamines from field stimulated rat brain slices. Acta physiol. scand., Suppl. 371, 35–44 (1971b)

    Google Scholar 

  • Graubner, W., Wolf, M.: Kritische Betrachtungen zum Wirkungsmechanismus des 2-(2,6-Dichlorphenylamino)-2-imidazolin-hydrochlorids. Arzneimittel-Forsch. 16, 1055–1058 (1966)

    Google Scholar 

  • Häggendal, J.: An improved method for fluorimetric determination of small amounts of adrenaline and noradrenaline in plasma and tissues. Acta physiol. scand. 59, 242–254 (1963)

    Google Scholar 

  • Häggendal, J., Johansson, B., Jonason, J., Ljung, B.: Effects of phenoxybenzamine on transmitter release and effector response in the isolated portal vein. J. Pharm. Pharmacol. 24, 161–164 (1972)

    Google Scholar 

  • Haeusler, G.: Clonidine-induced inhibition of sympathetic nerve activity: no indication for a central presynaptic or an indirect sympathomimetic mode of action. Naunyn-Schmiedeberg's Arch. Pharmacol. 286, 97–111 (1974)

    Google Scholar 

  • Hoefke, W., Kobinger, W.: Pharmakologische Wirkungen des 2-(2,6-Dichlorphenylamino)-2-imidazolin-hydrochlorids, einer neuen, antihypertensiven Substanz. Arzneimittel-Forsch. 16, 1038–1058 (1966)

    Google Scholar 

  • Kehr, W., Carlsson, A., Lindqvist, M.: A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 274, 273–280 (1972)

    Google Scholar 

  • Kirpekar, S. M., Puig, M.: Effect of flow-stop on noradrenaline release from normal spleens and spleens treated with cocaine, phentolamine or phenoxybenzamine. Brit. J. Pharmacol. 43, 359–369 (1971)

    Google Scholar 

  • Kobinger, W., Pichler, L.: The central modulatory effect of clonidine on the cardiodepressor relfex after suppression of synthesis and storage of noradrenaline. Europ. J. Pharmacol. 30, 56–62 (1975)

    Google Scholar 

  • Kobinger, W., Walland, A.: Facilitation of vagal reflex bradycardia by an action of clonidine on central α-receptors. Europ. J. Pharmacol. 19, 210–217 (1972)

    Google Scholar 

  • Maj, J., Sowińska, H., Baran, L., Kapturkiewicz, Z.: The effect of clonidine on locomotor activity in mice. Life Sci. 11 (1), 483–491 (1972)

    Google Scholar 

  • Mantel, N., Valand, R. S.: A technique of nonparametric multivariate analysis. Biometrics 26, 547–558 (1970)

    Google Scholar 

  • Modigh, K.: Central and peripheral effects of 5-hydroxytryptophan on motor activity in mice. Psychopharmacologia (Berl.) 23, 48–54 (1972)

    Google Scholar 

  • Nickerson, M.: The pharmacology of adrenergic blockade. Pharmacol. Rev. 1, 27–101 (1949)

    Google Scholar 

  • Papeschi, R., Sourkes, T. L., Youdim, M. B. H.: The effect of yohimbine on brain serotonin metabolism, motor behavior and body temperature of the rat. Europ. J. Pharmacol. 15, 318–326 (1971)

    Google Scholar 

  • Rand, M. J., Story, D. F., Allen, G. S., Glover, A. B., McCulloch, M. W.: Pulse-to-pulse modulation of noradrenaline release through a prejunctional α-receptor auto-inhibitory mechanism. In: Frontiers in catecholamine research, E. Usdin and S. H. Snyder, eds., pp. 579–581. Oxford: Pergamon Press 1973

    Google Scholar 

  • Sanghvi, I., Gershon, S.: Similarities between behavioral and pharmacological actions of yohimbine and 5-hydroxytryptophan in the conscious dog. Europ. J. Pharmacol. 11, 125–129 (1970)

    Google Scholar 

  • Schmitt, H., Schmitt, H.: Interactions between 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan®) and α-adrenergic blocking drugs. Europ. J. Pharmacol. 9, 7–13 (1970)

    Google Scholar 

  • Schmitt, H., Schmitt, H., Fénard, S.: Evidence for an α-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane. Europ. J. Pharmacol. 14, 98–100 (1971)

    Google Scholar 

  • Schmitt, H., Schmitt, H., Fénard, S.: Action of α-adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine. Arzneimittel-Forsch. 23, 40–45 (1973)

    Google Scholar 

  • Spector, S., Sjoerdsma, A., Udenfriend, S.: Blockade of endogenous norepinephrine synthesis by α-methyltyrosine, an inhibitor of tyrosine hydroxylase. J. Pharmacol. exp. Ther. 147, 86–95 (1965)

    Google Scholar 

  • Starke, K.: Influence of extracellular noradrenaline on the stimulation-evoked secretion of noradrenaline from sympathetic nerves: evidence for an α-receptor-mediated feed-back inhibition of noradrenaline release. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 11–23 (1972)

    Google Scholar 

  • Starke, K., Altmann, K. P.: Inhibition of adrenergic neurotransmission by clonidine: an action on prejunctional α-receptors. Neuropharmacology 12, 339–347 (1973)

    Google Scholar 

  • Starke, K., Montel, H.: Involvement of α-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones. Neuropharmacology 12, 1073–1080 (1973)

    Google Scholar 

  • Starke, K., Montel, H., Gayk, W., Merker, R.: Comparison of the effects of clonidine on pre- and postsynaptic adrenoceptors in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch. Pharmacol. 285, 133–150 (1974)

    Google Scholar 

  • Thoenen, H., Hürlimann, A., Haefely, W.: Dual site of action of phenoxybenzamine in the cat's spleen: blockade of α-adrenergic receptors and inhibition of re-uptake of neurally released norepinephrine. Experientia (Basel) 20, 1–5 (1964a)

    Google Scholar 

  • Thoenen, H., Hürlimann, A., Haefely, W.: Wirkungen von Phenoxybenzamin, Phentolamin und Azapetin auf adrenergische Synapsen der Katzenmilz: Blockierung der α-adrenergischen Rezeptoren und Hemmung der Wiederaufnahme von neural freigesetztem Noradrenalin. Helv. physiol. pharmacol. Acta 22, 148–161 (1964b)

    Google Scholar 

  • Yonkman, F. F., Stilwell D., Jeremias, R.: The adrenolytic and sympatholytic actions of yohimbine and ethyl yohimbine. J. Pharmacol. exp. Ther. 81, 111–115 (1944)

    Google Scholar 

  • Youmans, P. L., Green, H. D., Denison, A. B. Jr.: Nature of the vasodilator and vasoconstrictor receptors in skeletal muscle of the dog. Circulat. Res. 3, 171–180 (1955)

    Google Scholar 

  • Zimmerman, B. G., Ji Chia Liao, Gisslen, J.: Effect of phenoxybenzamine and combined administration of iproniazid and tropolone on catecholamine release elicited by renal sympathetic nerve stimulation. J. Pharmacol. exp. Ther. 176, 603–610 (1971)

    Google Scholar 

  • Zwieten, P. A. van: The central action of antihypertensive drugs mediated via central α-receptors. J. Pharm. Pharmacol. 25, 89–95 (1973)

    Google Scholar 

Download references

Author information

Author notes

  1. Maria Grabowska

    Present address: Institute of Pharmacology, Polish Academy of Sciences, PL-31-344, Kraków, Poland

Authors and Affiliations

  1. Department of Pharmacology, University of Göteborg, Fack, S-400 33, Göteborg 33, Sweden

    Nils-Erik Andén, Maria Grabowska & Ulf Strömbom

Authors
  1. Nils-Erik Andén
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Grabowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ulf Strömbom
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andén, NE., Grabowska, M. & Strömbom, U. Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 43–52 (1976). https://doi.org/10.1007/BF00506488

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00506488

Key words

Search

Navigation